AstraZeneca completes purchase of rare disease specialist Alexion Pharmaceuticals

Delaware Business Now

Jul 23, 2021

Reading Time: < 1 minute AstraZeneca completed the $39 billion acquisition of Alexion Pharmaceuticals, Inc. The closing of the acquisition marks the company's entry into medicines…